The TGA Laboratories will be testing herbal medicines that may contain arbutin. The limit of arbutin in therapeutic goods that are finished products is 25ppm. Below this concentration, supply is legal, above this concentration, products would face regulatory compliance actions.
Please note that the down-scheduling application for arbutin remains under TGA assessment and will not be finally determined until 2020 or 2021.
For more information and a list of possibly affected herbs, please find today's technical alert here.
